Roflumilast

Roflumilast

SCHEMBL18095182

O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1.O=C(Nc1c(Cl)cncc1Cl)c1ccc(OC(F)F)c(OCC2CC2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Roflumilast. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PDE4B known ✓ Q07343 20/20 1.00
PDE4D known ✓ Q08499 18/20 1.00
PDE4A known ✓ P27815 8/20 1.00
PDE4C known ✓ Q08493 8/20 1.00
ABCB11 O95342 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Roflumilast SCHEMBL19158 1.00 PDE4B (1.00) PDE4BPDE4DPDE4APDE4CABCB11
Roflumilast SCHEMBL29349467 1.00 PDE4B (1.00) PDE4BPDE4DPDE4APDE4CABCB11
Roflumilast SCHEMBL29033058 0.99 PDE4B (0.98) PDE4BPDE4DPDE4APDE4CABCB11
Roflumilast SCHEMBL29039838 0.99 PDE4B (0.98) PDE4BPDE4DPDE4APDE4CABCB11
Roflumilast SCHEMBL28150332 0.99 PDE4B (0.98) PDE4BPDE4DPDE4APDE4CABCB11
Roflumilast SCHEMBL20677818 0.98 PDE4B (0.96) PDE4BPDE4DPDE4APDE4CABCB11
Roflumilast SCHEMBL29191360 0.98 PDE4B (0.96) PDE4BPDE4DPDE4APDE4CABCB11
SCHEMBL2885525 0.96 PDE4B (0.93) PDE4BPDE4DPDE4APDE4CABCB11
SCHEMBL30084825 0.96 PDE4B (0.93) PDE4BPDE4DPDE4APDE4CABCB11
SCHEMBL2887750 0.96 PDE4B (0.92) PDE4BPDE4DPDE4APDE4CABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3270921-A1 COMPOSITIONS AND METHODS FOR TREATING COPD AND OTHER INFLAMMATORY CONDITIONS Georgia State University Research Foundation, Inc. (US) 2018-01-24 EP disclosed
WO-2016154143-A1 COMPOSITIONS AND METHODS FOR TREATING COPD AND OTHER INFLAMMATORY CONDITIONS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2016-09-29 WO disclosed